Methods of screening for .beta.-amyloid peptide production inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5604102
SERIAL NO

08143697

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Processing of .beta.-amyloid precursor protein (.beta.APP) is monitored by detecting the secretion of a soluble amino-terminal fragment or .beta.APP (ATF-.beta.APP) resulting from cleavage of .beta.APP at the amino-terminus of .beta.-amyloid peptide. Secretion of ATF-.beta.APP in animal models may be monitored to identify inhibitors of .beta.-amyloid production. The ATF-.beta.APP may be detected using antibodies and other specific binding substances which recognize a carboxy terminal residue on the fragment. Animals expressing the Swedish mutation of .beta.APP are described which produce abundant amounts of ATF-.beta.APP.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELAN PHARMACEUTICALS INC800 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
McConlogue, Lisa C San Francisco, CA 7 272
Schenk, Dale B Pacifica, CA 134 5655
Seubert, Peter A South San Francisco, CA 33 1397
Sinha, Sukanto San Francisco, CA 43 833
Zhao, Jun La Jolla, CA 550 12849

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation